Show on globe

Tampax TSS Advertising and Litigation

Forgotten Adverts · 1980–1993

Archived on

Region

United States; Spain

Associated With

Tampax Inc. / Tambrands - advertiser and manufacturer

Defining Feature

A brand education campaign alongside new federal warnings and case-specific litigation

Status

Ended

Overview

Tampax’s 1980s advertising unfolded as toxic shock syndrome changed how tampons were discussed and labelled.

The syndrome was recognised in menstruating women in 1980. Later CDC work linked risk particularly to the withdrawn Rely tampon and to absorbency, while an early 52-case study had not found a significant difference by brand or labelled absorbency. Rely was a Procter & Gamble product, not Tampax.

Tampax says it began a TSS education campaign during the decade. In 1982, the FDA required TSS information and warnings on menstrual-tampon packaging. Individual suits involving Tampax followed their own evidence and legal questions; they did not produce one universal verdict on the brand or on tampon use.

Why It Mattered

Risk information moved into the consumer’s encounter with the product itself. A health issue previously carried through medical studies and news coverage now also appeared in regulated package warnings and company education.

That makes the episode more than a story about one advert. It shows advertising, public-health regulation and litigation responding to the same concern through different rules of evidence. Tampax’s 1985 television claim to have used the word “period” belongs to that wider shift toward more direct language, but it should not be mistaken for proof about medical causation or the outcome of any case.

What the medical evidence established

  • The 1980 study associated menstrual TSS with tampon use but did not find a significant brand difference in its 52-case sample.
  • Later CDC analysis reported substantially greater risk among users of Rely and increasing risk with absorbency.

The 1982 warning rule

  • The FDA required TSS information and a package alert for covered menstrual tampons.
  • The rule put continuing risk information alongside the consumer product rather than leaving it only in news and clinical material.

Advertising responded separately

  • Tampax’s own history says it ran a TSS education campaign during the 1980s.
  • The company also dates a television advert using the word period to 1985; the exact first-broadcast claim remains a company account.
  • A contemporary Spanish letter described a Tampax advertisement responding to TSS reports; it does not establish identical US advertising.

Litigation was case-specific

  • Varley concerned a wrongful-death claim involving Tampax Super and turned on its own evidence and procedure.
  • Sloman considered warning and punitive-damages claims, including federal pre-emption; neither decision was a universal verdict on tampon use.
Selected Sources

Gallery

Blue-and-white FDA poster with a crowd illustration, the heading Toxic Shock Syndrome and a boxed list of symptoms and instructions.
Source
Credit

U.S. Food and Drug Administration; National Library of Medicine

Licence

Public domain

The source identifies this image as public domain.

Caption

A 1985 FDA poster warned tampon users about toxic shock syndrome symptoms and urged immediate medical attention.